副甲状腺体体积和治疗耐药性在患有二次性副甲状腺症的患者:一个4年的追溯队列研究
Kazuhiko Kato1,2,3, Akio Nakashima1, Masamitsu Morishita3
1Division of Nephrology and Hypertension, Department of Internal Medicine, Jikei University School of Medicine, Tokyo, Japan.
Clinical kidney journal
|February 10, 2025
概括
副甲状腺 (PTG) 超声波可以预测二次性副甲状腺炎患者的较高形剂量. 通过超声波测量较大的PTG体积表明随着时间的推移,对模治疗的需求越来越大.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 内分泌学 在内分泌学.
- 医疗成像医学成像
背景情况:
- 二次性甲状腺功能障碍症在血液透析患者中很常见.
- 副甲状腺 (PTG) 超声波在用仿药治疗二次性副甲状腺功能障碍症中的作用正在演变.
- PTG超声波可能有助于评估模治疗耐药性和手术时间.
研究的目的:
- 为了研究副甲状腺体 (PTG) 体积与二次性副甲状腺症患者的形剂量相关的假设.
- 为了确定PTG超声波能否预测长期的测量要求.
主要方法:
- 对血液透析门诊患者的回顾性研究,随访时间为4年.
- 在基线和4年后通过超声波测量甲状腺 (PTG) 体积.
- 检查了基线PTG体积和随访时的测量剂量之间的关联.
主要成果:
- 基线PTG体积与4年后的cinacalcet-equivalent calcimimetic剂量显著相关 (相关系数0.46,P<.001).
- 与没有结节的患者相比,PTG体积大于500mm3的患者需要大约80mg/天的更高形剂量.
- 多变量分析证实PTG体积> 500mm3作为高相剂量的预测指标在4年.
结论:
- 副甲状腺 (PTG) 超声波是评估二次性副甲状腺炎症的一个有价值的工具.
- PTG体积可以预测未来的测量剂量要求.
- 对PTG体积的超声波评估可以指导二次性偏甲状腺症的治疗策略.
相关概念视频
The Parathyroid Glands
1.8K
The two pairs of parathyroid glands embedded within the posterior surface of the thyroid gland are restricted by a dense capsule around them. These glands comprise two distinct cell populations—parathyroid oxyphil and parathyroid principal cells- pivotal in calcium homeostasis.
Oxyphil cells, whose functions remain elusive, emerge during late puberty, adding a layer of complexity to the parathyroid gland's intricacies. In contrast, principal parathyroid cells undertake a vital role by...
Oxyphil cells, whose functions remain elusive, emerge during late puberty, adding a layer of complexity to the parathyroid gland's intricacies. In contrast, principal parathyroid cells undertake a vital role by...
1.8K
Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
131
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
131
Hormones and Bone Tissue
2.6K
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
2.6K
Antihypertensive Drugs: Potassium-Sparing Diuretics
439
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
439
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
131
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
131


